Addex raises $2.8 million via ATM offering, extends cash runway to Q4 2027
Geneva-based Addex Therapeutics sold ADSs to H.C. Wainwright & Co. under its at-the-market agreement, pushing its projected cash runway into the fourth quarter of 2027.
SEC filing